Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 Friday, June 6th

All events take place in the Hynes Convention Center unless otherwise noted.
 

6:00 a.m. – 5:30 p.m.

Registration
 
 
6:30 a.m. – 8:00 a.m.
Breakfast Session 
 
 
B4: Current Management of Vasculargraft Infections from Head to Toes, Ballroom C, Level 3
At the end of this session, participants should be able to:
  1. Identify clinical presentation and risk factors for most common vascular infections
  2. Describe technical aspects of vascular reconstructive techniques using extra-anatomic or in situ arterial reconstruction with autologous vein, cryopreserved arterial allografts and rifampin-soaked grafts 
  3. Analyze outcomes of contemporary reports dealing with infected aortic stent-grafts, lower extremity and carotid reconstructions
Moderators: Gustovo S. Oderich MD, Mayo Clinic, Rochester, MN
Amy B. Reed MD, Penn State Heart and Vascular Institute, Hershey, PA

6:30 am 
Treatment Challenges and Outcomes in Patients with Infected Aortic Stent- Grafts
Manju Kalra MD, Mayo Clinic, Rochester, MN

6:45 am
Techniques and How to Minimize Complications When Using Femoral Vein Grafts to Treat Vascular Infections
R. James Valentine, MD, University of Texas South Western, Dallas TX

7:00 am
Tips and Tricks to Deal with Infected Groin 
Joseph S. Giglia MD, University of Cincinnati, Cincinnati OH

7:15 am
Update on management of infected carotid patch 
Patrick A. Stone MD, West Virginia University, Charleston, WV

7:30 am
Panel Discussion
 
 
B5: Optimizing Wound Care and Amputation Management, Room 304/306
At the end of this session, participants should be able to
  1. Identify useful adjunctive methods that will assist in healing chronic wounds associated with PAD
  2. Analyze opportunities for system improvement in managing patients with vascular disease and chronic wounds to improve limb preservation
  3. Predict patients at high risk for amputation complications and employ strategies for prevention to increase healing and preserve function.
Moderators:   William A. Marston MD, University of North Carolina School of Medicine, Chapel Hill, NC
Marc A. Passman MD, University of Alabama at Birmingham, Birmingham, AL

6:30 am
Importance of Optimal Wound Care in Maximizing Outcomes in Patients with Peripheral Vascular Disease 
William A. Marston MD, University of North Carolina School of Medicine, Chapel Hill, NC

6:45 am
Understanding the Advantages of a Wound Care Center 
William J. Ennis MD, University of Illinois Hospital & Health Sciences System, Chicago, IL

7:00 am
Amputation Complications: How to Prevent Them
Amir F. Azarbal MD, Oregon Health & Science University, Portland, OR

7:15 am
Evidence-Based Guidelines for Wound Care and Vascular Surgeons
Marc A. Passman MD, University of Alabama at Birmingham, Birmingham, AL

7:30 am
Panel Discussion
 
 
 
B6: The Role of Vascular Surgery During Multispecialty Operations, Room 312
At the end of this session, participants should be able to:
  1. Formulate management plans to repair traumatic injuries to the popliteal artery.
  2. Describe techniques for exposure and repair of vascular injuries incurred during spine and hip surgery.
  3. Demonstrate methods of management of infrainguinal vascular injuries.
  4. Illustrate methods of exposure of the IVC and portal vein for repair of iatrogenic injury.
  5. Explain the concepts for choosing open versus endovascular repair of common femoral and profunda femoral injuries.
  6. Measure the impact of the Vascular surgeon as a master surgeon on the complexity of procedures performed at your hospital.
Moderators: Michael B. Silva, Jr. MD FACS, The University of Texas Medical Branch, Galveston, TX
Mark F. Conrad MD MMSc, Massachusetts General Hospital, Boston, MA

6:30 am
Management of Popliteal Injury after Iatrogenic/ Accidental Trauma
Charlie C. Cheng MD, The University of Texas Medical Branch, Galveston, TX

6:40 am
Management of Major Vessel Injury During Spinal/ Hip Surgery
Virendra I. Patel MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA
   
6:50 am
Management of Infrainguinal Vascular Trauma, Vein and Artery
William D. Clouse MD, UC Davis Vascular Center, Sacramento, CA
       
7:00 am
Management of Portal/IVC Injuries During Non-Vascular Procedures
Louis M. Messina MD, University of Massachusetts Medical School, Worcester, MA

7:10 am
Management of Common/Profunda Femoral Injuries (infected, iatrogenic, trauma) is there an Endovascular Role?
David H. Stone MD, Dartmouth Hitchcock Medical Center, Lebanon, NH

7:20 am
Vascular Surgeons, Rescue, and Concept of Master Surgeon
Michael B. Silva, Jr. MD FACS, the University of Texas Medical Branch, Galveston, TX

7:30 am
Panel Discussion
 
 
B10: Population-Based Health Services Research:  When, Where, How, and Why, Room 302 
At the end of this session, participants should be able to:
  1. Describe the characteristics of large, population-based datasets and attributes of studies where they can be used effectively.
  2. Understand the complexities of obtaining access to large national datasets.
  3. Outline basic and advanced analytic methods commonly used in outcomes research.
  4. Convey the added value in health policy related to vascular disease that can be garnered by research using large, population-based datasets.

Moderators: Philip P. Goodney MD, Dartmouth-Hitchcock Clinic, Lebanon, NH
Marc L. Schermerhorn MD, Beth Israel Deaconess Medical Center, Boston, MA

6:30 am
WHEN is it Best to Study a Research Question using Large, Population-based Datasets such as Administrative Claims or NIS? 
Jason Wiseman MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

6:45 am
WHERE Can Researchers get Access to Population-based Resources for Research? 
Todd R. Vogel MD MPH, University of Missouri Hospital & Clinics, Columbia, MO

7:00 am
HOW Should Surgical Investigators Design Their Analyses and Execute Their Research?
Matthew A. Corriere MD MS, Wake Forest University School of Medicine, Winston-Salem, NC

7:15 am
WHY can Population-based Datasets be a Good Resource to Influence Health Policy for Patients with Vascular Disease?
Matthew W. Mell MD, Stanford University, Stanford, CA

7:30 am
Panel Discussion
 
 
6:30 a.m. – 8:00 a.m.
General Surgery Resident/Medical Student Program Breakfast/Surgical Skills Competition 
(see Fellow/Resident/Student program for more details​)​
 
 
8:00 a.m. – 9:30 a.m.
S4: SVS Plenary Session IV, Ballroom A/B, Level 3
 
8:00 a.m.
SS15. A Randomized Controlled Trial of Domain-Specific Cognitive Function After Carotid Endarterectomy and Stenting
Panos Kougias, Nicholas Pastorek, Robert Collins, Sally A. McCoy, Sherene Sharath, Briauna Lowery, Shalinie Mukhi, Katie McCulloch, Carlos Bechara, Neal R. Barshes, George Pisimisis, David Berger
 
8:14 a.m.
SS16. Potential of Preoperative Frailty Risk Analysis Index to Stratify Patients Undergoing Carotid Endarterectomy Management and Outcomes:  A 10-Year Experience
Alyson Melin, Kendra K. Schmid, Thomas G. Lynch, Steven Kappes, Iraklis I. Pipinos, Matthew G. Longo, Prateek K. Gupta, Jason M. Johanning
 
8:28 a.m.
VS4. Anatomical Exposure of Thoracic Outlet with Supraclavicular Approach and Resection of Cervical Rib
Himanshu Verma,  Ramesh K. Tripathi
 
8:38 a.m.
SS17. Cognitive Effects of Carotid Disease and Carotid Interventions
Wei Zhou
 
8:52 a.m.
SS18. The Effect of Beta Blockade on Operative Mortality:  Harmful or Helpful?
Mark Friedell, Charles VanWay, Ronald Freyberg, Peter Almenoff
 
9:06 a.m.
SS19. Prospective, Randomized, Multi-Institutional Clinical Trial of a Silver Alginate Dressing to Reduce Lower Extremity Vascular Surgery Wound Complications
C. Keith Ozaki, Allen D. Hamdan, Neal R. Barshes, Mark C. Wyers, Nathanael D. Hevelone, Michael Belkin, Louis L. Nguyen
 
9:30 a.m. – 4:30 p.m.
Exhibit Hall Open
 
9:30 AM - 10:00 AM
Vascular Live: Exhibit Hall C, Vascular Live Stage, Level 2 
HeRo Graft Clinical Update sponsored by CryoLife, Inc., Shawn Gage, PA-C
 
9:30 AM - 10:00 AM
Vascular Live: Exhibit Hall D Vascular Live Stage, Level 2
Real World Intravascular Robotics Implementation:  Clinical Experiences and Lessons Learned sponsored by Hansen Medical, John Matsuuura, MD
*Vascular Live Presentations are not part of the ACCME accredited portion of the Vascular Annual Meeting
 
9:30 a.m. – 10:00 a.m.
Coffee Break
 
 
10:00 a.m. – 11:05 a.m.
F2: Projects and Reports from the Vascular Quality Initiative, Ballroom A/B, Level 3
At the end of this session, participants should be able to:
  1. Identify opportunities for regional quality improvement initiatives.
  2. Identify the regional and patient-specific variations in use of completion imaging for lower extremity bypass

Moderators: Richard P. Cambria, MD, Massachusetts General Hospital, Boston, MA
Jack L. Cronenwett MD, Dartmouth- Hitchcock Medical Center, Lebanon, NH

10:00 am
Annual Report
Richard P. Cambria, MD, Massachusetts General Hospital, Boston, MA

10:10 am
Regional Differences in Patient Selection and Treatment of AAA, Lower Extremity and Carotid Artery Disease in the SVS Vascular Quality Initiative 

10:20 am
Factors that Increase Length of Stay after EVAR in the Vascular Quality Initiative

10:30 am
Variations in the Practice Patterns of Intra-operative Completion Imaging for Lower Extremity Bypass in the Vascular Quality Initiative

10:40 am
A Comparison of Superficial Femoral Artery Treatment Strategies for Critical Limb Ischemia in the Vascular Quality Initiative

10:50 am
Pre-operative beta-blockers prior to major elective vascular surgery does not improve cardiac outcomes and may be harmful
 
 
11:05 a.m. – 12:15 p.m.
SVS Presidential Address, Ballroom A/B, Level 3
 
11:05 a.m.
Introduction
Peter F. Lawrence, MD
 
11:20 a.m.
Of Strategies and Chances
Julie Ann Freischlag, MD
 
12:15 p.m. - 12:45 p.m.
Vascular Live:  Exhibit Hall C Vascular Live Stage, Level 2
Branched Device Clinical Trials from Gore sponsored by Gore and Associates
Darren Schneider, MD, Michael D. Dake, MD
 
12:15 p.m. - 12:45 p.m.
Vascular Live: Exhibit Hall D Vascular Live Stage Level 2
The FUSION BIOLINE Heparin Coated Vascular Graft:  Superior Patency and Improved Outcomes Compared to the Standard ePTFE Grafts sponsored by MAQUET Medical Systems
Alan Lumsden, MD
 
12:45 p.m. - 2:15 p.m.
Vascular Live: Exhibit Hall C Vascular Live Stage Level 2
Type B Dissection:  Who Should be treated with TEVAR? sponsored by Gore and Associates
Alan Lumsden, MD
*Vascular Live Presentations are not part of the ACCME accredited portion of the Vascular Annual Meeting
 
12:15 p.m. – 1:30 p.m.
SVS Member Business Luncheon, Ballroom C, Level 3 
 
  
12:15 p.m. – 1:30 p.m.
Non-Member Lunch in Exhibit Hall C&D, Level 2
 
 
1:30 p.m. – 3:00 p.m.
S5: SVS Plenary Session V, Ballroom A/B, Level 3
Moderators: Ronald L. Dalman, MD, Ravi K. Veeraswamy, MD
 
1:30 p.m.
SS20. Mortality Benefits of Different Hemodialysis Access Types Are Age-Dependent
Caitlin W. Hicks, Joseph K. Canner, Isibor Arhuidese, Umair Qazi, Natalia O. Glebova, Julie Ann Freischlag, Mahmoud B. Malas
 
1:44 p.m.
SS21. Dialysis Access-Associated Steal Syndrome
Andrew E. Leake, Daniel G. Winger, Steven A. Leers, NavYash Gupta, Michel S. Makaroun, Ellen D. Dillavou
 
1:58 p.m.
SS22. AV Fistula for Hemodialysis: Benchtop to Bedside
Eric T. Choi
 
2:12 p.m.
VS5. Human Tissue-Engineered Grafts for Hemodialysis: Development, Preclinical Data, and Early Investigational Human Implant Experience
Jeffrey H. Lawson, Shannon Dahl, Heather Prichard, Roberto Manson, Shawn Gage, Alan Kypson, Juliana Blum, Alison Pilgrim, William Tente, Laura Niklason
 
2:22 p.m.
SS23. Clinical Outcomes and Cost Effectiveness of Initial Treatment Strategies for Non-Embolic Acute Limb Ischemia in Real-Life Clinical Settings
Anthony J. Comerota, Varun Vaidya, Fedor Lurie
 
2:36 p.m.
SS24. Lessons Learned in the Surgical Treatment of Neurogenic Thoracic Outlet Syndrome over 10 Years
Kendall Likes, Megan S. Orlando, Serene Mirza, Quinn Salditch, Anne Cohen, Ying W. Lum, Thomas Reifsnyder, Julie Ann Freischlag
 
3:00 - 3:30 p.m.
Vascular Live: Exhibit Hall C Vascular Live Stage, Level 2
Clinical Experience Treating Highly Angulated AAAs On-Label using the Aorfix Endovascular Stent Graft sponsored by Lombard Medical Technologies, Inc., Mark Fiillinger, MD
*Vascular Live Presentations are not part of the ACCME accredited portion of the Vascular Annual Meeting
 
 
3:00 p.m. – 3:30 p.m.
Coffee Break
 
 
 
Concurrent Breakout Sessions
 
 
3:30 p.m. – 5:00 p.m.
C5: SVS/ESVS Joint S​ession​, Ballroom A/B, Level 3
At the end of this session, participants should be able to:
  1. Compare conventional and endovascular treatment methods and outcomes for patients with ​thoracoabdomial aortic aneurysms
  2. Evaluate the methodology and outcomes of the randomized clinical trials of percutaneous renal artery intervention to determine whether the conclusions are relevant to treatment of renal artery occlusive disease
  3. Assess the differences of open surgical and endovascular approaches to popliteal artery aneurysms and determine whether successful treatment requires surgical bypass
Moderators: Julie Ann Freischlag MD, UC Davis School of Medicine, Sacramento, CA (SVS)
Phillipe Kohl, MD PhD, University Hospital of Liège, Liège , Belgium (ESVS)
Bruce A. Perler, MD, Johns Hopkins Hospital, Baltimore, MD (SVS)
Jean Baptiste Ricco, MD PhD, University of Poitiers, Poitiers, France (ESVS)

Debate 1
3:30 pm
Thoracoabdominal aneurysms
“Fenestrated and branched grafts are the optimal way to treat thoracoabdominal aortic anerusysms.”
Stéphan Haulon, MD, PhD, Hospital Cardiologique, Lille, France (ESVS) 
 
3:45 pm
“Open surgical repair is still the best way to treat thoracoabdomial aortic aneurysms.”
Richard P. Cambria, MD, Massachusetts General Hospital, Boston, MA (SVS) 

Debate 2
4:00 pm
Renal artery stenosis
“With the results of the ASTRAL and the CORAL trials, there is no indication to percutaneously treat renal artery occlusive disease.”
George Hamilton MD, University College London, London, United Kingdom (ESVS) 

4:15 pm
“These trials do not answer the important questions; there are still indications to treat renal artery occlusive disease.”
Matthew A. Corriere MD, Wake Forest University School of Medicine, Winston-Salem, NC (SVS) 

Debate 3
4:30 pm
Popliteal artery aneurysm
"Popliteal artery aneurysms can be successfully treated by endograft exclusion of the aneurysm."
Luke K. Marone, MD, University of Pittsburgh, Pittsburgh, PA (SVS) 

4:45 pm
"Surgical repair remains the gold standard and the optimal method to treat a popliteal artery aneurysm." 
Jean-Baptiste Ricco, MD, PhD, University Hospital J Bernard, Poitiers, France (ESVS) 
 
3:30 p.m. - 5:00 p.m.
C6: SVS/STS Joint Session, Room 312
At the end of this session, participants should be able to:
  1. Formulate a plan based on published data for management of patients with severe carotid stenosis undergoing CABG surgery 
  2. Identify treatment options for patients with acute and chronic type B dissection
  3. Describe the advantages and disadvantages of best medical management versus endovascular intervention in type B dissection 
Moderators: Keith B. Allen MD, Mid America Heart & Lung Surgeons, Kansas City, MO
Jeffery B. Dattilo MD, The Surgical Clinic, St. Thomas Health, Nashville, TN

3:30 pm
Contemporary Management of Type B Aortic Dissection
STS: Michael J. Reardon MD, The Methodist DeBakey Heart & Vascular Center, Houston, TX 
SVS: Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA 

4:00 pm
Discussion 

4:15 pm
Management of Severe Carotid Stenosis in Patients Undergoing CABG Surgery 
STS: Keith B. Allen MD, Mid America Heart & Lung Surgeons, Kansas City, MO 
SVS: Jeffery B. Dattilo MD, The Surgical Clinic, St. Thomas Health, Nashville, TN

4:45 pm
Discussion
 
 
 
C7: Collaborating on Resident/Student Education:  Opportunities for Education Abroad and in North America, Room 311
At the end of this session, participants should be able to:
  1. Examine the reasons for participating in supplemental resident/student training opportunities abroad or in the U.S.
  2. Identify barriers and solutions for participating in supplemental resident/student training opportunities abroad or in the U.S.
Moderators: John E. Rectenwald, MD, University of Michigan Health System, Ann Arbor, M  Gustavo Oderich, MD, Mayo Clinic, Rochester, MN

3:30 pm
Introduction
John E. Rectenwald, MD, University of Michigan Health System, Ann Arbor, MI

International Opportunities for U.S. Trainees
3:35 pm
Why Go Abroad During Your Training?
Peter Gloviczki, MD, Mayo Clinic, Rochester, MN

3:45 pm
What You Need to Know from ACGME 
Linda M. Harris, MD University of Buffalo, Buffalo, NY 

3:55 pm
What You Need to Know from the ABS 
Vivian Gahtan, MD, SUNY Upstate Medical University, Syracuse, NY

4:05 pm
My International Training Experience 
Adam Beck, MD, University of Florida, Gainesville, FL

U.S. Opportunities for International Trainees
4:15 pm
Opportunities for International Trainees
Igor L. Banzic, Surgery Clinical Center of Serbia, Belgrade, Serbia (5 minutes each)
Enrico Ascher, MD, Lutheran Medical Center, Brooklyn, NY (5 minutes each)

4:25 pm
How to Structure a Program for International Trainees
Matthew Eagleton, MD, Cleveland Clinic, Cleveland, OH

4:35 pm
My U.S. Training Experience 
Nirvana Sadaghianloo, MD, University of Nice – Sophia Antipolis, France

4:45 pm
Panel Discussion
 
 
3:30 pm - 5:00 pm
C8: Poster Session, Auditorium Level 2

5:00 p.m. – 6:00 p.m.
General Surgery Resident/Medical Student Program Residency Fair 
(see Fellow/Resident/Student program for more details​)​

 

 

 
​​ ​​
​​

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.